Page last updated: 2024-08-17

triamcinolone acetonide and Waldenstrom Macroglobulinemia

triamcinolone acetonide has been researched along with Waldenstrom Macroglobulinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Degenring, RF; Jonas, JB; Kreissig, I	1

Other Studies

1 other study(ies) available for triamcinolone acetonide and Waldenstrom Macroglobulinemia

Article	Year
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy. European journal of ophthalmology, 2003, Volume: 13, Issue:6 Topics: Aged; Anti-Inflammatory Agents; Eye; Humans; Injections; Intraocular Pressure; Iris; Ischemia; Male; Neovascularization, Pathologic; Ocular Hypotension; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body; Vitreous Hemorrhage; Waldenstrom Macroglobulinemia	2003

Article

Year

Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.

European journal of ophthalmology, 2003, Volume: 13, Issue:6

Topics: Aged; Anti-Inflammatory Agents; Eye; Humans; Injections; Intraocular Pressure; Iris; Ischemia; Male; Neovascularization, Pathologic; Ocular Hypotension; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body; Vitreous Hemorrhage; Waldenstrom Macroglobulinemia

2003